Uscom Limited (UCM.AX)
AUD 0.03
(19.05%)
AUD 0.03
(19.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 2.07 Million AUD | -2.93% |
| 2023 | 2.13 Million AUD | 3.81% |
| 2022 | 2.05 Million AUD | -8.85% |
| 2021 | 2.25 Million AUD | -9.53% |
| 2020 | 2.49 Million AUD | 283.27% |
| 2019 | 650.98 Thousand AUD | 22.65% |
| 2018 | 530.75 Thousand AUD | -25.06% |
| 2017 | 708.23 Thousand AUD | -8.47% |
| 2016 | 773.75 Thousand AUD | 19.46% |
| 2015 | 647.69 Thousand AUD | 43.99% |
| 2014 | 449.81 Thousand AUD | -2.32% |
| 2013 | 460.52 Thousand AUD | 28.53% |
| 2012 | 358.29 Thousand AUD | -7.82% |
| 2011 | 388.68 Thousand AUD | 1.91% |
| 2010 | 381.38 Thousand AUD | -18.73% |
| 2009 | 469.3 Thousand AUD | 32.46% |
| 2008 | 354.31 Thousand AUD | -19.18% |
| 2007 | 438.38 Thousand AUD | -31.64% |
| 2006 | 641.3 Thousand AUD | 72.18% |
| 2005 | 372.46 Thousand AUD | 0.0% |
| 2003 | 75.05 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 3.87 Million AUD | 0.0% |
| 2024 FY | 2.07 Million AUD | -2.93% |
| 2024 Q4 | 2.07 Million AUD | 0.0% |
| 2023 Q2 | 1.9 Million AUD | 0.0% |
| 2023 Q4 | 2.13 Million AUD | 0.0% |
| 2023 FY | 2.13 Million AUD | 3.81% |
| 2022 FY | 2.05 Million AUD | -8.85% |
| 2022 Q2 | 2.2 Million AUD | 0.0% |
| 2022 Q4 | 2.05 Million AUD | 0.0% |
| 2021 FY | 2.25 Million AUD | -9.53% |
| 2021 Q4 | 2.25 Million AUD | 0.0% |
| 2021 Q2 | 2.07 Million AUD | 0.0% |
| 2020 Q4 | 2.49 Million AUD | 0.0% |
| 2020 FY | 2.49 Million AUD | 283.27% |
| 2020 Q2 | 2.38 Million AUD | 0.0% |
| 2019 FY | 650.98 Thousand AUD | 22.65% |
| 2019 Q2 | 628.88 Thousand AUD | 0.0% |
| 2019 Q4 | 650.98 Thousand AUD | 0.0% |
| 2018 Q2 | 592.8 Thousand AUD | 0.0% |
| 2018 FY | 530.75 Thousand AUD | -25.06% |
| 2018 Q4 | 530.75 Thousand AUD | 0.0% |
| 2017 Q4 | 708.23 Thousand AUD | 0.0% |
| 2017 FY | 708.23 Thousand AUD | -8.47% |
| 2017 Q2 | 760.66 Thousand AUD | 0.0% |
| 2016 Q4 | 773.75 Thousand AUD | 0.0% |
| 2016 Q2 | 791.18 Thousand AUD | 0.0% |
| 2016 FY | 773.75 Thousand AUD | 19.46% |
| 2015 Q2 | 554.24 Thousand AUD | 0.0% |
| 2015 FY | 647.69 Thousand AUD | 43.99% |
| 2015 Q4 | 647.69 Thousand AUD | 0.0% |
| 2014 Q2 | 332.93 Thousand AUD | 0.0% |
| 2014 FY | 449.81 Thousand AUD | -2.32% |
| 2014 Q4 | 449.81 Thousand AUD | 0.0% |
| 2013 FY | 460.52 Thousand AUD | 28.53% |
| 2013 Q4 | 460.52 Thousand AUD | 0.0% |
| 2012 FY | 358.29 Thousand AUD | -7.82% |
| 2012 Q4 | 358.29 Thousand AUD | 0.0% |
| 2011 Q4 | 388.68 Thousand AUD | 0.0% |
| 2011 FY | 388.68 Thousand AUD | 1.91% |
| 2010 Q4 | 381.38 Thousand AUD | 0.0% |
| 2010 FY | 381.38 Thousand AUD | -18.73% |
| 2009 FY | 469.3 Thousand AUD | 32.46% |
| 2009 Q4 | 469.3 Thousand AUD | 0.0% |
| 2008 FY | 354.31 Thousand AUD | -19.18% |
| 2008 Q4 | 354.31 Thousand AUD | 0.0% |
| 2007 FY | 438.38 Thousand AUD | -31.64% |
| 2007 Q4 | 438.38 Thousand AUD | 0.0% |
| 2006 FY | 641.3 Thousand AUD | 72.18% |
| 2006 Q4 | 641.3 Thousand AUD | 0.0% |
| 2005 Q4 | 372.46 Thousand AUD | 0.0% |
| 2005 FY | 372.46 Thousand AUD | 0.0% |
| 2003 FY | 75.05 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 95.776% |
| Adherium Limited | 3.4 Million AUD | 39.133% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 85.969% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -60.197% |
| Anteris Technologies Ltd | 17.03 Million AUD | 87.831% |
| Control Bionics Limited | 2.75 Million AUD | 24.86% |
| CardieX Limited | 8.56 Million AUD | 75.783% |
| Compumedics Limited | 22.14 Million AUD | 90.638% |
| Cochlear Limited | 904.6 Million AUD | 99.771% |
| CleanSpace Holdings Limited | 6.94 Million AUD | 70.163% |
| Cyclopharm Limited | 13.65 Million AUD | 84.814% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | 61.992% |
| Nova Eye Medical Limited | 8.55 Million AUD | 75.753% |
| HeraMED Limited | 1.5 Million AUD | -37.693% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 91.707% |
| ImpediMed Limited | 6.24 Million AUD | 66.786% |
| InhaleRx Limited | 911.41 Thousand AUD | -127.512% |
| LBT Innovations Limited | 5.5 Million AUD | 62.353% |
| Micro-X Limited | 12.63 Million AUD | 83.587% |
| Neurotech International Limited | 314.69 Thousand AUD | -558.907% |
| OncoSil Medical Limited | 1.98 Million AUD | -4.621% |
| PolyNovo Limited | 37.04 Million AUD | 94.402% |
| Respiri Limited | 3.55 Million AUD | 41.655% |
| SomnoMed Limited | 24.78 Million AUD | 91.632% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 80.461% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | 25.058% |